Aggregator
A methanogen hydrolase reveals the structure of archaeal peptidoglycan
A design approach for bitopic kinase inhibitors
Hepatocytes promote liver metastasis of pancreatic cancer by providing serine
Banking records reveal characteristics of financial abuse
Sequence-encoded hexagonal lattices in multichannel peptide nanofibrils
Lu<sup>+</sup> optical frequency references with accuracy verified at the 19th digit
Single-nucleus transcriptome-wide association study of human brain disorders
Gravitational torque drives multidecadal variations in length of day
The anthropogenic fingerprint on emerging infectious diseases
The gene-regulatory evolution of the human skeleton
Competition heats up in the regenerative-medicine ranks
Bank accounts reveal the fingerprints of abusive financial control
Chiral oxazolidinones <i>via</i> biocatalytic aziridination of unactivated alkenes
Author Correction: Large recoverable elastic energy in chiral metamaterials via twist buckling
How to stay smart in the age of AI: the science of critical thinking
In praise of human teachers: universities must resist outsourcing everything to AI
Huge hoard of metal bars hints at vast Iron Age trade
Project will harness technology to track Amazon biodiversity in real time
Leaders of $100 million effort will use automated detection methods and computer models to monitor species’ trends
Bones link 10,000-year-old temple complex to a village, not a ‘skull cult’
Landslides, not rituals, may have scattered skulls and bones at Turkey’s famed Göbekli Tepe site
This new drug could break cancer’s resistance to treatment
A new experimental drug called CS18 may help break through cancer drug resistance by disabling several of the defenses tumors use to survive treatment. It strengthened existing therapies, restored drug sensitivity in resistant lung cancer cells, and slowed tumor growth in animal models.